Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This protocol investigates the effect of a high dose dexamethasone regimen in the treatment
of postoperative pain following Transoral Robotic Surgery (TORS). The protocol consists of
three substudies.
1. Randomized double-blinded clinical trial assigning half of the participants to a
high-dose dexamethasone regimen while the other half will receive a low-dose
dexamethasone dosage and placebo in the first postoperative period.
2. A investigation of "Why in hospital?" following TORS. From the first postoperative day
until discharge reasons for continued hospitalization will be registered in order to
identify clinical and organizational factors contributing to hospitalization
3. An assessment of "Days Alive and Out of Hospital" following TORS. From the day of
surgery and the first 12 postoperative months all admissions to a hospital ward will be
registered along with admission reasons. Any death during the first 12 months will be
noted with a cause of death.
Phase:
Phase 3
Details
Lead Sponsor:
Rigshospitalet, Denmark
Collaborators:
Aarhus University Hospital Candys Foundation Odense University Hospital Region Capital Denmark